Current evidence for COVID-19 therapies: a systematic literature review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current evidence for COVID-19 therapies: a systematic literature review
Authors
Keywords
-
Journal
European Respiratory Review
Volume 30, Issue 159, Pages 200384
Publisher
European Respiratory Society (ERS)
Online
2021-03-18
DOI
10.1183/16000617.0384-2020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
- (2021) Romina Libster et al. NEW ENGLAND JOURNAL OF MEDICINE
- HHS Funds Development of Antibiotic to Treat Anthrax
- (2020) Rita Rubin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Framework for Rationing Ventilators and Critical Care Beds During the COVID-19 Pandemic
- (2020) Douglas B. White et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
- (2020) Yang Cao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fair Allocation of Scarce Medical Resources in the Time of Covid-19
- (2020) Ezekiel J. Emanuel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- (2020) Wei Tang et al. BMJ-British Medical Journal
- Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
- (2020) Annemarie B Docherty et al. BMJ-British Medical Journal
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
- (2020) Caleb P. Skipper et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
- (2020) Effat Davoudi-Monfared et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Organ-specific manifestations of COVID-19 infection
- (2020) Maria Gavriatopoulou et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
- (2020) Christiane Maria Prado Jeronimo et al. CLINICAL INFECTIOUS DISEASES
- Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial
- (2020) Cesare Perotti et al. HAEMATOLOGICA
- Febuxostat therapy in outpatients with suspected COVID‐19: A clinical trial
- (2020) Lotfollah Davoodi et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Epidemiology of COVID‐19: A Systematic Review and Meta‐analysis of Clinical Characteristics, Risk factors and Outcomes
- (2020) Jie Li et al. JOURNAL OF MEDICAL VIROLOGY
- Estimates of the severity of coronavirus disease 2019: a model-based analysis
- (2020) Robert Verity et al. LANCET INFECTIOUS DISEASES
- Disease and healthcare burden of COVID-19 in the United States
- (2020) Ian F. Miller et al. NATURE MEDICINE
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- (2020) Alexandre B. Cavalcanti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- Coronavirus 2019 Disease (COVID‐19), Systemic Inflammation, and Cardiovascular Disease
- (2020) Riccardo M. Inciardi et al. Journal of the American Heart Association
- No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
- (2020) Yin-Qiu Huang et al. Frontiers in Pharmacology
- Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
- (2020) Christian Karagiannidis et al. Lancet Respiratory Medicine
- A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study
- (2020) Zhigang Ren et al. Advanced Science
- Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19
- (2020) Jun Chen et al. Open Forum Infectious Diseases
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019
- (2020) Spyridon G. Deftereos et al. JAMA Network Open
- Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
- (2020) Sherief Abd-Elsalam et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19
- (2020) Yohei Doi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of COVID-19 Patients with Prolonged Post-Symptomatic Viral Shedding with Leflunomide -- a Single-Center, Randomized, Controlled Clinical Trial
- (2020) Mengmei Wang et al. CLINICAL INFECTIOUS DISEASES
- Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19
- (2020) Julio Cesar Garcia de Alencar et al. CLINICAL INFECTIOUS DISEASES
- Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial
- (2020) Oriol Mitjà et al. CLINICAL INFECTIOUS DISEASES
- Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study
- (2020) Ting Li et al. CTS-Clinical and Translational Science
- Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
- (2020) Maryam Edalatifard et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
- (2020) Pierre-François Dequin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
- (2020) Anahita Sadeghi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial
- (2020) Hamideh Abbaspour Kasgari et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
- (2020) Girish N. Nadkarni et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
- (2020) Remo H M Furtado et al. LANCET
- Substantial underestimation of SARS-CoV-2 infection in the United States
- (2020) Sean L. Wu et al. Nature Communications
- Convalescent plasma for covid-19
- (2020) Lise J Estcourt et al. BMJ-British Medical Journal
- Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
- (2020) Sophie Juul et al. PLOS MEDICINE
- Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia
- (2020) Lin-ling Cheng et al. JAMA Internal Medicine
- Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
- (2020) Khalil Ansarin et al. BioImpacts
- Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
- (2020) Wesley H. Self et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
- (2020) Anna Cristina Bertoldi Lemos et al. THROMBOSIS RESEARCH
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Phillip D Monk et al. Lancet Respiratory Medicine
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started